Cervical cancer patients with a low expression of ITM2A were more likely to have adenocarcinoma or adenosquamous carcinoma, while cervical cancer patients with a high expression of ITM2A tended to have squamous carcinoma. Here, ITM2A is linked to squamous cell carcinoma.